Atara Biotherapeutics Stock Forecast

Buy or Hold candidate since Oct 14, 2024 Gain 59.88%

The Atara Biotherapeutics stock price gained 4.16% on the last trading day (Friday, 6th Dec 2024), rising from $12.51 to $13.03. During the last trading day the stock fluctuated 5.88% from a day low at $12.51 to a day high of $13.24. The price has risen in 6 of the last 10 days and is up by 22.81% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 11 thousand more shares were traded than the day before. In total, 64 thousand shares were bought and sold for approximately $835.74 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 53.08% during the next 3 months and, with a 90% probability hold a price between $16.90 and $23.94 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock. Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)

ATRA Signals & Forecast

The Atara Biotherapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $12.59 and $10.93. A breakdown below any of these levels will issue sell signals. Atara Biotherapeutics has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, November 13, 2024, and so far it has fallen -8.63%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Atara Biotherapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $11.77 and $11.63. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Atara Biotherapeutics finds support just below today's level at $11.77. If this is broken, then the next support from accumulated volume will be at $11.63 and $10.28.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.736 between high and low, or 5.88%. For the last week, the stock has had daily average volatility of 8.65%.

Our recommended stop-loss: $12.44 (-4.51%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 16 days ago.)

Trading Expectations (ATRA) For The Upcoming Trading Day Of Monday 9th

For the upcoming trading day on Monday, 9th we expect Atara Biotherapeutics to open at $12.93, and during the day (based on 14 day Average True Range), to move between $11.99 and $14.07, which gives a possible trading interval of +/-$1.04 (+/-7.99%) up or down from last closing price. If Atara Biotherapeutics takes out the full calculated possible swing range there will be an estimated 15.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $13.14 (0.84%) than the support at $11.77 (9.67%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Atara Biotherapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Atara Biotherapeutics stock to perform well in the short-term.

Current score: 3.246 Buy Candidate Unchanged

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on December 9, 2024 - $12.93 ( 0.80%).